282
J. Broeker et al. / Tetrahedron: Asymmetry 20 (2009) 273–287
20:1?PE/E 5:1) ester 8d (0.335 g, 98%) was obtained as colourless
4.9. 2-Methyl-3-phenylpropanoic acid (1R,2S)-1,2-bis(2-
methylphenyl)-2-(2-methylpropoxy)ethyl ester 9b
crystals {Fp = 54 °C; ½a D20
ꢂ
¼ þ13:9 (c 0.70, CH2Cl2)}; 1H NMR (CDCl3,
200 MHz) d 7.73–7.35 (m, 8H, Ph-H), 6.44/4.97 (2d, J = 7.4 Hz, 2H,
OCHPh), 2.94/2.85 (2dd, J1 = 8.8 Hz, J2 = 6.3 Hz, 2H, O–
CH2CH(CH3)2), 2.13 (q, J = 7.5 Hz, 2H, OCO–CH2CH3), 1.71–1.51
(m, 1H, O–CH2CH(CH3)2), 0.91 (t, J = 7.6 Hz, 3H, OCO–CH2CH3),
0.65/0.64 (2d, J = 6.8 Hz, 6H, O–CH2CH(CH3)2); 13C NMR (CDCl3,
50 MHz) d 172.2 (O–CO), 138.2/137.4 (q, J(C,F) = 1.4 Hz, Ph-C-1),
132.0/131.6 (q, J(C,F) = 0.9 Hz, Ph-C-4), 129.5/128.6/128.1/128.1
(Ph-C-5, Ph-C-6), 129.45/129.18 (q, J(C,F) = 30.5 Hz, Ph-C-2),
125.7/125.0 (q, J(C,F) = 5.8 Hz, Ph-C-3), 124.3/124.1 (2q,
J(C,F) = 274.1/274.5 Hz, CF3), 79.0/72.8 (q, J = 0.9/2.2 Hz, OCHPh),
75.9 (O–CH2CH(CH3)2); 28.2 (O–CH2–CH(CH3)2), 27.3 (CO–CH2–
The synthesis was carried out as described above (Section 4.8)
using 8b (0.100 g, 0.282 mmol). After chromatography (PE/E
50:1?E) 9b (0.114 g, 99%) was obtained as a yellow oil (1H NMR
(CDCl3, 200 MHz) d 7.45–6.99 (m, 13H, Ph-H), 6.17/6.16 (2d(diast.),
J = 6.8/6.5 Hz, 1H, Ph-CH–OCO), 4.85/4.81 (2d(diast.), J = 6.8/6.5 Hz,
1H, Ph-CH-O), 3.14–2.82 (m, 3H, O–CH2CH(CH3)2, CO–CH(CH3)–
CH2Ph), 2.74–2.47 (m, 2H, CO–CH(CH3)–CH2Ph), 2.42 (s, 3H, Ph-
CH3), 2.30/2.26 (2s(diast.), 3H, Ph-CH3), 1.84–1.65 (m, J = 6.6 Hz,
1H, OCH2CH(CH3)2), 1.00/0.98 (2d(diast.), J = 6.7 Hz, 3H, CO–
CH(CH3)–CH2Ph), 0.79 (d, J = 6.7 Hz, 6H, OCH2CH(CH3)2); 13C
NMR (CDCl3, 50 MHz) d 174.5/174.4 (O–CO(diast.)), 139.1/139.1
(Ph-C-1(diast.)), 137.0/136.9/136.9/136.7/136.6/136.5/136.4 (Ph-
C-1, Ph-C–CH3(diast.)), 129.8–125.4 (Ph-C), 80.8/75.9 (OCHPh),
73.7/73.6 (OCH2CH(CH3)2(diast.)), 41.4/41.1 (CO–CH(CH3)–
CH2Ph(diast.)), 39.2/39.1 (CO–CH(CH3)–CH2Ph(diast.)), 28.5 (O–
CH2CH(CH3)2), 19.2/19.1 (O–CH2CH(CH3)2), 19.1/19.2 (Ph-CH3),
16.1/15.9 (CO–CH(CH3)–CH2Ph(diast.)); M = 444.62. Anal. Calcd
for C30H36O3: C, 81.04; H, 8.16. Found: C, 80.83; H, 8.19.
CH3),
18.9/18.9
(O–CH2–CH(CH3)2),
8.7
(CO–CH2–CH3);
M = 462.44. Anal. Calcd for C23H24F6O3: C, 59.74; H, 5.23; F,
24.65. Found: C, 59.87; H, 5.05; F, 24.83).
4.7. Propanoic acid (1R,2S)-2-(2-methoxyethoxy)-1,2-bis(2-
methoxyphenyl)ethyl ester 8e
The synthesis was carried out as described above (Section 4.3)
using 7e (0.200 g, 0.60 mmol). After chromatography (PE/E
20:1?PE/E 5:1) ester 8e (0.229 g, 98%) was obtained as a colour-
4.10. 2-Methyl-3-phenylpropanoic acid (1R,2S)-1,2-bis(4-
methoxyphenyl)-2-(2-methylpropoxy)ethyl ester 9c
less oil (½a 2D0
ꢂ
¼ þ17:8 (c 1.00, CH2Cl2)};1H NMR (CDCl3, 200 MHz)
d 7.26–6.60 (m, 9H, incl. 6.61 (d, J = 3.7 Hz, 1H, OCHPh), Ph-H),
5.22 (d, J = 3.7 Hz, 2H, OCHPh), 3.64–3.33 (m, 13H, incl. 3.60/
3.47/3.35 (3s, 9H, OCH3), OCH2CH2O), 2.36 (q, J = 7.5 Hz, 2H,
OCO–CH2CH3), 1.12 (t, J = 7.6 Hz, 3H, OCO–CH2CH3); 13C NMR
The synthesis was carried out as described above (Section 4.8)
using 8c (0.100 g, 0.26 mmol). After chromatography (PE/E
50:1?E) 9c (0.098 g, 79%) was obtained as a yellow oil (1H NMR
(CDCl3, 200 MHz) d 7.24–6.78 (m, 13H, Ph-H), 5.81/4.41 (2d(diast.),
J = 6.5 Hz, 2H, OCHPh), 3.80 (s, 6H, Ph-OCH3), 3.14–2.84 (m, 3H, O–
CH2CH(CH3)2, CO–CH(CH3)–CH2–Ph), 2.71–2.45 (m, 2H, CH2–Ph),
1.85–1.65 (m, 1H, O–CH2CH(CH3)2), 1.00/0.97 (2d(diast.), J = 6.8
Hz, 3H, CO–CH(CH3)–CH2–Ph), 0.79/0.78 (2d, J = 6.7 Hz, 6H, O-
CH2CH(CH3)2); 13C NMR (CDCl3, 50 MHz) d 174.6/174.5 (CO(-
diast.)), 159.2/159.1/159.1 (Ph-C-OCH3(diast.)), 139.3/130.8/
(CDCl3, 50 MHz)
d 173.1 (O–CO), 157.2/156.6 (Ph-C–OCH3),
128.4/128.2/128.2/127.7/126.0/125.9/119.8/119.64/109.6/109.4
(Ph-C), 75.8/71.8/70.3/68.9 (OCHPh, OCH2CH2O), 58.9/55.2/54.9
(OCH3), 27.8 (CO–CH2–CH3), 9.0 (CO–CH2–CH3); M = 388.46. Anal.
Calcd for C22H28O6: C, 71.48; H, 7.82. Found: C, 71.23; H, 7.86).
4.8. Typical procedure for the a-alkylation of esters 8a–8e; 2-
methyl-3-phenylpropanoic acid (1R,2S)-1,2-bis(2-methoxy-
130.0/129.9
(Ph-C-1(diast.)),
129.1/129.0/128.9/128.2/126.1/
phenyl)-2-(2-methylpropoxy) ethyl ester 9a
113.3/113.1 (Ph-C), 83.6/77.4 (CH-Ph), 75.9 (O–CH2–CH(CH3)2),
55.1 (Ph-OCH3), 41.4/41.3 (CO–CH(CH3)–CH2-Ph(diast.)), 39.3/
39.2 (CH2-Ph(diast.)), 28.5 (O–CH2–CH(CH3)2), 19.2 (O–CH2–
CH(CH3)2), 16.4/16.2 (CO–CH(CH3)–CH2-Ph(diast.)); M = 476.62.
Anal. Calcd for C30H36O5: C, 75.60; H, 7.61. Found: C, 75.30; H, 7.56.
Under a nitrogen atmosphere, diisopropylamine (0.052 g, 0.518
mmol) was dissolved in dry THF (0.5 mL), n-BuLi (0.205 mL, 0.510
mmol) was slowly added at ꢀ30 °C and the reaction mixture was
stirred for 30 min at ꢀ5 °C. At ꢀ70 °C ester 8a (100 mg, 0.259
mmol) dissolved in THF (2.5 mL) was added and after 90 min ben-
zyl bromide (354 mg, 2.07 mmol) was added dropwise and the
mixture was stirred for 1 h at ꢀ70 °C. The mixture was allowed
to reach rt, stirred for 1 h and quenched with water. The aqueous
phase was separated, extracted with ether, and the combined ether
phases were washed with KHSO4 solution (5%) and saturated NaH-
CO3 solution, dried, filtered and evaporated to dryness. After chro-
matography (PE/E 50:1?E) 9a (119 mg, 97%) was obtained as a
colourless oil (1H NMR (CDCl3, 200 MHz) d 7.30–6.71 (m, 13H,
Ph-H), 6.57 (d, J = 3.9 Hz, 1H, Ph-CH–OCO), 5.18/5.13 (2d(diast.),
J = 3.9 Hz, 1H, OCHPh), 3.59/3.58 (2s(diast.), 3H, Ph-OCH3), 3.55/
3.57 (2s(diast.), 3H, Ph-OCH3), 3.22–3.08 (m, 3H, O–CH2CH
(CH3)2,CO–CH(CH3)–CH2Ph), 2.86–2.58 (m, 2H, CO–CH(CH3)–
CH2Ph), 1.99–1.76 (m, J = 6.6 Hz, 1H, OCH2CH(CH3)2), 1.16/1.13
4.11. 2-Methyl-3-phenylpropanoic acid (1R,2S)-2-(2-methyl-
propoxy)-1,2-bis[2-(trifluoromethyl)phenyl]ethyl ester 9d
The synthesis was carried out as described above (Section 4.8)
using 8d (0.100 g, 0.216 mmol). After chromatography (PE/E
50:1?E) 9d (0.057 g, 48%) was obtained as a colourless oil (1H
NMR (CDCl3, 200 MHz) d 7.76–6.92 (m, 13H, Ph-H), 6.42/6.140
(2d(diast.), J = 7.3/7.5 Hz, 1H, Ph-CH–OCO), 4.98 (d, J = 7.6 Hz,
1H, Ph-CH–O), 3.00–2.35 (m, 5H, O–CH2CH(CH3)2, CO–CH(CH3)–
CH2Ph, CO–CH(CH3)–CH2Ph), 1.74–1.52 (m,
OCH2CH(CH3)2), 0.90/0.86 (2d(diast.), J = 6.2/6.8 Hz, 3H, CO–
CH(CH3)–CH2Ph), 0.65/0.64 (2d(diast.), 6.8/0.7 Hz, 6H,
J = 6.6 Hz, 1H,
J
=
OCH2CH(CH3)2); 13C NMR (CDCl3, 50 MHz) d 173.9/173.8 (CO(-
diast.)), 139.0/138.9 (benzyl.Ph-C-1(diast.)), 138.4/138.2/137.3/
137.3 (q, J(C,F) = 1.3/0.9/1.4/1.4 Hz, Ph-C-1(diast.)), 132.1/131.7
(Ph-C-4), 129.4/129.3/128.8/128.7/128.5/128.4/128.3/128.29/128.1/
128.1/128.0 (benzyl. Ph-C, Ph-C-5, Ph-C-6(diast.)), 129.5/129.4 (q,
J(C,F) = 29.9/30.1 Hz, Ph-C-2), 125.6/125.0/125.0 (q, J(C,F) = 5.6/
5.7/5.9 Hz, Ph-C-3(diast.)), 124.3/124.1 (q, J(C,F) = 274.4/274.3 Hz,
CF3), 79.1/72.9/72.9 (OCHPh(diast.)), 75.9 (O–CH2CH(CH3)2), 41.3/
41.0 (CO–CH(CH3)–CH2-Ph(diast.)), 39.4/38.9 (CH2-Ph(diast.)), 28.2
(O–CH2–CH(CH3)2), 18.9/18.8 (O–CH2–CH(CH3)2), 16.1/16.0 (CO–
CH(CH3)–CH2-Ph(diast.)); M = 552.56. Anal. Calcd for C30H30F6O3:
C, 65.21; H, 5.47. Found: C, 65.04; H, 5.58.
(2d(diast.),
J = 6.6 Hz, 3H, CO–CH(CH3)–CH2Ph), 0.92/0.90
(2d(diast.), J = 6.7 Hz, 6H, OCH2CH(CH3)2); 13C NMR (CDCl3, 50
MHz) d 174.6 (O–CO), 157.3/156.7 (Ph-C–OCH3), 139.5/139.4
(Ph-C-1(diast.)), 128.9–126.0 (Ph-C), 126.0/126.0 (Ph-C-1), 119.7/
119.6/109.6/109.4
(OCH2CH(CH3)2(diast.)), 55.2/55.0 (Ph-OCH3), 41.6/41.4 (CO–CH
(CH3)–CH2Ph(diast.)), 39.4/39.3 (CO–CH(CH3)–CH2Ph(diast.)),
(Ph-C)
76.1/75.7
(OCHPh),
70.7/70.7
28.6 (O–CH2CH(CH3)2), 19.28/19.26 (O–CH2CH(CH3)2), 16.4/16.3
(CO–CH(CH3)–CH2Ph(diast.)); M = 476.62. Anal. Calcd for
C30H36O5: C, 75.60; H, 7.61. Found: C, 75.62; H, 7.73.